Published in Am J Hematol on April 01, 2002
Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med (2005) 1.33
Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res (2008) 1.19
Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg (2003) 1.11
Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med (2008) 1.08
The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut (2007) 1.06
Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer. Virchows Arch (2010) 0.98
Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. Br J Cancer (2009) 0.97
Activation of blood coagulation in cancer: implications for tumour progression. Biosci Rep (2013) 0.94
Quantitative estimation of Serum Fibrinogen Degradation Product levels in Oral Premalignant and Malignant lesions. J Int Oral Health (2013) 0.93
Venous thromboembolism in malignant gliomas. J Thromb Haemost (2009) 0.92
Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients. J Immunoassay Immunochem (2010) 0.91
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell. Int J Colorectal Dis (2011) 0.89
Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model. J Thromb Haemost (2009) 0.89
Expression of protease-activated receptors and tissue factor in human liver. Virchows Arch (2005) 0.85
Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity. Cancer Immunol Res (2013) 0.84
Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. Transl Oncol (2011) 0.84
Tissue factor expression in the metaplasia-adenoma-carcinoma sequence of gastric cancer in a European population. Br J Cancer (2012) 0.84
Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma. Thromb Res (2012) 0.84
Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis. Int J Colorectal Dis (2011) 0.83
Regulating surgical oncotaxis to improve the outcomes in cancer patients. Surg Today (2013) 0.82
Angiogenesis factors involved in the pathogenesis of colorectal cancer. Curr Health Sci J (2013) 0.81
Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data. Phys Med Biol (2012) 0.81
The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells. J Thromb Haemost (2012) 0.81
VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese. Int J Med Sci (2008) 0.79
Antiangiogenic therapy in human gastrointestinal malignancies. Gut (2006) 0.79
Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas. Cancers (Basel) (2011) 0.77
Changes in the Laboratory Data for Cancer Patients Treated with Korean-medicine-based Inpatient Care. J Pharmacopuncture (2014) 0.77
A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model. J Cancer Res Clin Oncol (2013) 0.77
Association Between Vascular Endothelial Growth Factor Gene Polymorphisms with Breast Cancer Risk in an Iranian Population. Breast Cancer (Auckl) (2016) 0.76
Vascular endothelial growth factor (VEGF) receptor expression correlates with histologic grade and stage of colorectal cancer. Libyan J Med (2010) 0.76
D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma. BMC Musculoskelet Disord (2011) 0.75
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis (2013) 2.30
Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura. J Allergy Clin Immunol (2013) 2.00
Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg (2010) 1.95
Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab (2003) 1.92
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol (2009) 1.89
Trigeminal neuralgia: evaluation of neuralgic manifestation and site of neurovascular compression with 3D CISS MR imaging and MR angiography. Radiology (2003) 1.76
Features of early gastric cancer and gastric adenoma by enhanced-magnification endoscopy. J Gastroenterol (2006) 1.75
Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology (2012) 1.66
Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Clin Cancer Res (2005) 1.57
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele. Cytotherapy (2012) 1.55
Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost (2005) 1.55
Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol (2004) 1.55
Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. Cancer Res (2009) 1.55
Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Respir Med (2010) 1.54
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity. Blood (2011) 1.54
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood (2002) 1.52
Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care (2003) 1.49
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses. Blood (2007) 1.47
Molecular diagnosis of prosthetic valve endocarditis with aorto-right atrial fistula. Int J Cardiol (2008) 1.46
Patients with a hypertensive response to exercise have impaired left ventricular diastolic function. Hypertens Res (2008) 1.45
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res (2006) 1.42
Haemostatic abnormalities and thrombotic disorders in malignant lymphoma. Thromb Haemost (2005) 1.42
Molecular diagnosis of nonaneurysmal infectious aortitis. J Vasc Surg (2010) 1.42
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J Clin Invest (2006) 1.41
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun (2007) 1.34
KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol (2009) 1.32
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med (2009) 1.31
Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol (2008) 1.31
Retracted Positive feedback regulation between Akt2 and MyoD during muscle differentiation. Cloning of Akt2 promoter. J Biol Chem (2002) 1.28
CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. Int Immunol (2008) 1.27
Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. J Exp Med (2005) 1.26
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc Natl Acad Sci U S A (2003) 1.26
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci U S A (2005) 1.24
Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today (2005) 1.23
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals. Clin Cancer Res (2010) 1.22
Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. Blood (2003) 1.21
Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. Cancer Res (2008) 1.20
A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res (2005) 1.18
Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) (2010) 1.13
mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies. Int J Cancer (2004) 1.12
Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock (2009) 1.11
Is early treatment of disseminated intravascular coagulation beneficial in septic patients? Crit Care (2014) 1.11
Hematopoietic origin of hepatic stellate cells in the adult liver. Blood (2007) 1.11
Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. Int J Cancer (2009) 1.11
Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Mol Immunol (2013) 1.10
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Blood (2011) 1.10
Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem (2003) 1.09
Intravital imaging of DSS-induced cecal mucosal damage in GFP-transgenic mice using two-photon microscopy. J Gastroenterol (2010) 1.09
In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. Am J Respir Crit Care Med (2003) 1.08
Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost (2010) 1.07
Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas. Cancer Res (2003) 1.07
De novo CD5-positive diffuse large B-cell lymphoma of the temporal bone presenting with an external auditory canal tumor. Intern Med (2006) 1.07
The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today (2006) 1.06
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Clin Cancer Res (2006) 1.05
Effects of cerebral ischemia on evoked cerebral blood oxygenation responses and BOLD contrast functional MRI in stroke patients. Stroke (2006) 1.05
A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes. J Leukoc Biol (2005) 1.04
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients. Int J Cancer (2007) 1.03
Radiation induces epithelial-mesenchymal transition in colorectal cancer cells. Oncol Rep (2011) 1.03
Reprogramming of human postmitotic neutrophils into macrophages by growth factors. Blood (2003) 1.03
IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. J Immunol (2005) 1.03
Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion (2002) 1.03
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol (2008) 1.03
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica (2008) 1.02
Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. J Clin Exp Hematop (2011) 1.01
Development of mixed-type autoimmune hemolytic anemia and Evans' syndrome following chicken pox infection in a case of low-titer cold agglutinin disease. Int J Hematol (2006) 1.01
Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey. Thromb Res (2012) 1.00
Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care (2006) 1.00
Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery. Int J Hematol (2009) 1.00
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology (2005) 1.00
Superior mesenteric artery syndrome in an infant: case report and literature review. J Pediatr Surg (2007) 0.99
Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells. Eur J Immunol (2009) 0.99
Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cells. J Immunol (2010) 0.99
Efficacy of a novel class of RNA interference therapeutic agents. PLoS One (2012) 0.99
Notch ligand Delta-1 differentially modulates the effects of gp130 activation on interleukin-6 receptor alpha-positive and -negative human hematopoietic progenitors. Cancer Sci (2007) 0.99
Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int J Oncol (2011) 0.99
Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Sci (2007) 0.99
Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med (2003) 0.98